Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Advanced Solid Tumor × Bosentan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 1

Interventions

ulixertinib 1 tislelizumab 1 talazoparib 1 olaparib 1 lenvatinib 1 erdafitinib 1 atezolizumab 1 Ramucirumab 1 PM 01183 1 Injections 1 IFL protocol 1 Gemcitabine 1 Bosentan 1 BID protein, human 1 Appointments and Schedules 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05072106 2025-09-16

Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors

PharmaMar

Phase 1 Completed

11 enrolled 26 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡